Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Santen Pharmaceutical Co. Ltd.

www.santen.com

Latest From Santen Pharmaceutical Co. Ltd.

Deal Watch: Roche And Vividion Will Investigate E3 Ligases In Cancer, Immunology

Also, news on transactions involving Neurocrine/Idorsia, Neurotrope/Metuchen, jCyte/Santen, PTC/Censa, Hoth/Chelexa, Skyhawk/Merck & Co., Orexo/Gaia, Karo/J&J, MaxCyte/Caribou, Mediolanum/ElsaLys, Avectas/ONK

Deals Business Strategies

Oxford Biomedica Transforms With New Deals, R&D Pipeline, And Manufacturing Facilities

The lentivirus gene delivery company, Oxford Biomedica, is to collaborate with Juno Therapeutics on its CAR-T and TCR-T projects, adding to the UK biotech’s transformation into a debt-free company with a growing in-house product pipeline.

Deals Gene Therapy

Glaukos Lowers 2020 Guidance, Citing 'Competitive Headwind' In MIGS Business

Glaukos Corp. said it expects rising competition in the US microinvasive glaucoma surgery (MIGS) space in 2020 from Ivantis along with surgical procedures.

Ophthalmic Ophthalmology

Crunch Time For Protection Of New Therapeutic Uses In Europe

The pharmaceutical industry will be watching carefully as the EU Court of Justice deliberates on whether to deny or widen the granting of supplementary protection certificates on new therapeutic indications of authorized medicines.

Europe Intellectual Property
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Santen Pharmaceutical Co. Ltd.
  • Senior Management
  • Akira Kurokawa, Chmn. & CEO
    Shigeo Taniuchi, Pres. & COO
  • Contact Info
  • Santen Pharmaceutical Co. Ltd.
    Phone: (81) 6-6321-7000
    4-20 Ofuka-cho, Kita-ku
    Osaka, 530-8552
    Japan
UsernamePublicRestriction

Register